The World Health Organization (WHO) says the Malawian government should consider quickly adopting the new typhoid vaccine Typbar-TCV as the new routine treatment for the disease.   WHO Malawi representative...

At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting...